1. Home
  2. PGEN

as 09-11-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Founded: 1998 Country:
United States
United States
Employees: N/A City: GERMANTOWN
Market Cap: 493.0M IPO Year: N/A
Target Price: $7.50 AVG Volume (30 days): 18.8M
Analyst Decision: Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.43 EPS Growth: N/A
52 Week Low/High: $0.65 - $5.22 Next Earning Date: 08-12-2025
Revenue: $4,340,000 Revenue Growth: -1.12%
Revenue Growth (this year): 253.63% Revenue Growth (next year): 699.64%

PGEN Daily Stock ML Predictions

Stock Insider Trading Activity of Precigen Inc. (PGEN)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
AGEE NANCY H PGEN Director Sep 4 '25 Buy $4.60 15,000 $69,000.00 217,841
AGEE NANCY H PGEN Director Aug 28 '25 Buy $4.65 10,645 $49,490.73 217,841
AGEE NANCY H PGEN Director Aug 19 '25 Buy $3.20 15,360 $49,152.00 217,841

Share on Social Networks: